Here is a review of a presentationby Dr. Ravi at ASCO 2023, regarding measuring the PSA at 6 months post radiation treatment, for all risk groups. He found that the 6-month post-RT PSA was highly prognostic of 5- and 10-year rates of metastasis free survival (MFS), Overall Survival (OS), and prostate cancer mortality (PCSM). They looked at over 10,000 patients over a period of 10 years, and found that if your 6-month PSA is 0.1, then you might need to intensify the ADT treatment (longer course and/or adding extra drugs).
PSA 6 months after RT: Here is a review... - Prostate Cancer N...
PSA 6 months after RT
IMO, very wrong to lump risk groups. Very few favorable risk patients today would get ADT and their PSA at 6 months post RT would be way higher than 0.1, yet would have excellent prognosis. Also, for men taking ADT, PSA≤0.1 is common. It is only prognostic if a high risk patient has not responded to ADT.
That's a valid criticism. Usually they report outcomes for a selected risk group.
This was an extended Abstract presentation at ASCO 2013. He probably only had 10 minutes to talk. It was a large study, over 10,000 patients covering 10 years of data from the ICECAP database. I'm sure that when they eventually publish a complete paper, they will report the results for individual risk groups.
I think the key finding is that, in general, the PSA level (at 6-months post RT) is highly predictive of future outcomes, with PSA = 0.1 being a critical level.
Just reporting what was presented. I don't have an opinion about their conclusions.
Don't shoot the messenger..........(been there, done that and can show you the bullet holes in my done that tee shirt....)....
Good Luck, Good Health and Good Humor.
j-o-h-n Friday 01/12/2024 7:31 PM EST
Thanks. I'm learning.